Perry Yin
About Perry Yin
Perry Yin is the Director of Strategy & Operations for Worldwide Value, Access, and Pricing & HEOR at Bristol Myers Squibb, with a background in market access and strategic consulting.
Company
Perry Yin is currently employed at Bristol Myers Squibb. He holds the position of Director, Strategy & Operations - Worldwide Value, Access, and Pricing & HEOR. Bristol Myers Squibb is based in Princeton, New Jersey, United States.
Title
Perry Yin serves as the Director of Strategy & Operations - Worldwide Value, Access, and Pricing & HEOR at Bristol Myers Squibb. In this role, he supports the leadership team in areas related to value, access, and health economics outcomes research (HEOR).
Education and Expertise
Perry Yin has an extensive educational background in biomedical engineering. He obtained a Doctor of Philosophy (Ph.D.) in Biomedical Engineering from Rutgers University, where he studied from 2010 to 2016. Prior to that, he received a Bachelor of Science (B.S.) in Biomedical Engineering from Columbia University, where he studied from 2006 to 2010.
Professional Background
Before joining Bristol Myers Squibb, Perry Yin worked at Novartis as Director, Market Access Innovation, from 2020 to 2022 in East Hanover, New Jersey, United States. He also held positions at GLG (Gerson Lehrman Group) as Manager, Strategic Projects, from 2019 to 2020, and at PA Consulting as Consultant from 2016 to 2019 in New York, New York, United States.
Achievements
During his tenure at Novartis, Perry Yin led initiatives to establish more sustainable drug pricing and patient access models, including value-based pricing for value-based access. At GLG, he managed and sold over 40 consulting and market research projects, covering strategy, business development, and R&D. His role also involved leading deal development, from scoping and proposal creation to pitching, negotiating, and contracting.